Skip to main content

The 2022 French Strategy on biotherapies and bioproduction of advanced therapies: results after 3 years launch and perspectives

Presentation on French Strategy at EuroGCT Lunchtime Symposium during the ESGCT Congress, 10 October 2025, Sevilla, Spain. 

The EuroGCT Lunchtime Symposium provides an overview and discusses with policy- and law-makers, and regulators, the policy strategies at stake and their current and prospective impact on the regulation of gene and cell therapy in Europe.

 

presentation:

The 2022 French Strategy on biotherapies and bioproduction of advanced therapies: results after 3 years launch and perspectives

 

Speaker: 

Emmanuel Dequier, Project officer in Health Innovation at the Ministry of Higher Education and Research

 

The 2022 French Strategy on biotherapies and bioproduction of advanced therapies: results after 3 years launch and perspectives

 

Please download and view the PDF file of this presentation from the attachment section below.

Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts